SavedAdd your journal

Journals / Türk Kadın Sağlığı ve Neonatoloji Dergisi / 2023 / Volume: 5 Issue: 4

Indications and results of prenatal invasive diagnosis (amniocentesis, chorionic villus sampling, cordocentesis): A tertiary center experience

Prenatal invaziv tanı endikasyonları ve sonuçları (amniyosentez, koryon villus örneklemesi, kordosentez): Tersiyer bir merkez deneyimi

Zeynep Şeyhanlı(Ankara Etlik Şehir Hastanesi)0000-0003-3924-3723
Betül Tokgöz(Ankara Etlik Şehir Hastanesi)0000-0003-0202-4981
Can Ozan Ulusoy(Ankara Etlik Şehir Hastanesi)0009-0005-7931-5172
Sadun Sucu(Ankara Etlik Şehir Hastanesi)0000-0003-3758-0136
Gülşan Karabay(Ankara Etlik Şehir Hastanesi)0000-0003-2567-2850
Abdüllatif Bakır(Ankara Etlik Şehir Hastanesi)0000-0002-3931-4168
Cantekin İskender(Ankara Etlik Şehir Hastanesi)0000-0003-1376-5734
Şevki Çelen(Ankara Etlik Şehir Hastanesi)0000-0003-1349-1569
Pages
—
Publication Date
2023-12-28
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, the decision to undergo these procedures should be made thoughtfully, with careful consideration of patient counselling and informed consent.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To evaluate the indications for prenatal invasive procedures and karyotype results in pregnant women Materials and Methods: We conducted a retrospective analysis of the indications and karyotype results of pregnant women who opted for invasive diagnostic testing in a tertiary center between September 2022 and May 2023.
📊
Key Findings & Data:Results: Of the 331 patients who underwent prenatal genetic diagnosis, 267 underwent amniocentesis (80.7%), 62 underwent chorionic villus sampling (18.7%), and 2 underwent cordocentesis (0.6%).
💡
Conclusion & Impact:However, the decision to undergo these procedures should be made thoughtfully, with careful consideration of patient counselling and informed consent.
🔬Design:Research Article
📍Scope:2022 Verileri
⚙️Variables:amniocentesis · chorionic villus sampling · cordocentesis

Abstract

Objective: To evaluate the indications for prenatal invasive procedures and karyotype results in pregnant women Materials and Methods: We conducted a retrospective analysis of the indications and karyotype results of pregnant women who opted for invasive diagnostic testing in a tertiary center between September 2022 and May 2023. Results: Of the 331 patients who underwent prenatal genetic diagnosis, 267 underwent amniocentesis (80.7%), 62 underwent chorionic villus sampling (18.7%), and 2 underwent cordocentesis (0.6%). The most common indication for amniocentesis was an elevated risk in first-trimester screening tests (29.6%). Chorionic villus sampling was most frequently performed due to an increased risk in the first-trimester screening test (37.1%) and because of an increased nuchal translucency (37.1%). Cordocentesis was exclusively performed in cases of abnormal second-trimester ultrasound examinations. Trisomy 21 was most frequently detected in cases with increased nuchal translucency (13.3%). Conclusions: The importance of invasive prenatal diagnostic procedures for the early detection and diagnosis of genetic disorders and the assessment of fetal health is evident. However, the decision to undergo these procedures should be made thoughtfully, with careful consideration of patient counselling and informed consent.

Özet

Amaç: Gebelerin prenatal invaziv işlem endikasyonlarını ve karyotip sonuçlarını değerlendirmek. Gereç ve Yöntem: Eylül 2022 ile Mayıs 2023 tarihleri arasında tersiyer bir merkezde invaziv tanı testi önerilen gebe kadınlar için endikasyonların ve karyotip sonuçlarının retrospektif bir analizini yaptık. Bulgular: Prenatal genetik tanı konulan 331 hastanın 267’sine amniyosentez (%80.7), 62’sine koryon villus örneklemesi (%18.7) ve 2’sine (%0.6) kordosentez uygulandı. Amniyosentez için en sık endikasyon ilk trimester tarama testlerinde riskin yüksek çıkmasıydı (%29.6). İlk trimester tarama testinde riskin artışı (%37.1) ve ense kalınlığının artışı (%37.1) nedeniyle en sık koryon villus örneklemesi yapıldı. Kordosentez yalnızca anormal ikinci trimester ultrason muayenesi vakalarında yapıldı. Trizomi 21 en sık ense kalınlığının arttığı olgularda (%13.3) tespit edildi. Sonuç: Genetik bozuklukların erken tespiti ve tanısı ile fetal sağlığın değerlendirilmesinde invaziv prenatal tanı prosedürlerinin önemi açıktır. Ancak bu prosedürleri uygulama kararı, hasta danışmanlığı ve bilgilendirilmiş onam dikkate alınarak dikkatli bir şekilde verilmelidir.

🔖

Cite This Article

Şeyhanlı, Z., Tokgöz, B., Ulusoy, C. O., Sucu, S., Karabay, G., Bakır, A., İskender, C., Çelen, Ş. (2023). Indications and results of prenatal invasive diagnosis (amniocentesis, chorionic villus sampling, cordocentesis): A tertiary center experience. Türk Kadın Sağlığı ve Neonatoloji Dergisi, Volume: 5 Issue: 4. https://doi.org/10.46969/EZH.1390109

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Centers for Disease Control and Prevention (CDC). Update on overall prevalence of major birth defects--Atlanta, Georgia, 1978-2005. MMWR Morb Mortal Wkly Rep. 2008 Jan 11;57(1):1–5.
  2. Milunsky A, Milunsky JM. Genetic Disorders and the Fetus: Diagnosis, Prevention, and Treatment. John Wiley & Sons; 2015. 1216 p.
  3. Practice Bulletin No. 163: Screening for Fetal Aneuploidy. Obstet Gynecol. 2016 May;127(5):e123–37.
  4. Kagan KO, Sonek J, Kozlowski P. Antenatal screening for chromosomal abnormalities. Arch Gynecol Obstet. 2022 Apr;305(4):825–35.
  5. Nussbaum RL, McInnes RR, Willard HF. Thompson & Thompson Genetics in Medicine E-Book: Thompson & Thompson Genetics in Medicine E-Book. Elsevier Health Sciences; 2015. 561 p.
  6. Bulletins—Obstetrics AC of O and GC on P, Genetics C on, Medicine S for MF, Bulletins—Obstetrics AC of O and GC on P, Genetics C on, Medicine S for MF, et al. Screening for Fetal Chromosomal Abnormalities: ACOG Practice Bulletin, Number 226. Obstetrics & Gynecology [Internet]. 2020 Oct [cited 2023 Nov 5];136(4):e48. Available from: https://journals.lww.com/greenjournal/Fulltext/2020/10000/Screening_for_Fetal_Chromosomal_Abnormalities_.44.aspx?casa_token=r_qGWAu6yf8AAAAA:JuZigmyJFtj2cAlOj8Mv7rDfvQOMOjlyy7RYQ7P-3AtzZm-4f27VJOEC6hkiQX7c3BbhR754073EIqVttDvQ236m-YjqDOI
  7. Alamillo CML, Krantz D, Evans M, Fiddler M, Pergament E. Nearly a third of abnormalities found after first-trimester screening are different than expected:10-year experience from a single center. Prenatal Diagnosis [Internet]. 2013 [cited 2023 Nov 5];33(3):251–6. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/pd.4054
  8. Ball RH, Caughey AB, Malone FD, Nyberg DA, Comstock CH, Saade GR, et al. First- and Second-Trimester Evaluation of Risk for Down Syndrome. 2007;110(1).
  9. Nicolaides KH, Heath V, Cicero S. Increased fetal nuchal translucency at 11–14 weeks. Prenatal Diagnosis [Internet]. 2002 [cited 2023 Nov 5];22(4):308–15. Available from: https://onlinelibrary.wiley.com/doi/abs/10.1002/pd.308
  10. Alldred SK, Takwoingi Y, Guo B, Pennant M, Deeks JJ, Neilson JP, et al. First trimester ultrasound tests alone or in combination with first trimester serum tests for Down’s syndrome screening. Cochrane Database of Systematic Reviews [Internet]. 2017 [cited 2023 Nov 6];(3). Available from: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD012600/full
  11. Practice Bulletin No. 175: Ultrasound in Pregnancy. Obstetrics & Gynecology [Internet]. 2016 Dec [cited 2023 Nov 5];128(6):e241. Available from: https://journals.lww.com/greenjournal/abstract/2016/12000/practice_bulletin_no__175__ultrasound_in_pregnancy.53.aspx
  12. Bromley B, Lieberman E, Shipp TD, Benacerraf BR. The Genetic Sonogram. Journal of Ultrasound in Medicine [Internet]. 2002 [cited 2023 Nov 5];21(10):1087–96. Available from: https://onlinelibrary.wiley.com/doi/abs/10.7863/jum.2002.21.10.1087
  13. Ravitsky V, Roy MC, Haidar H, Henneman L, Marshall J, Newson AJ, et al. The Emergence and Global Spread of Noninvasive Prenatal Testing. Annu Rev Genomics Hum Genet. 2021 Aug 31;22:309–38.
  14. Jummaat F, Ahmad S, Ismail NAM. 5-Year review on amniocentesis and its maternal fetal complications. Hormone Molecular Biology and Clinical Investigation [Internet]. 2019 Nov 1 [cited 2023 Nov 5];40(2). Available from: https://www.degruyter.com/document/doi/10.1515/hmbci-2019-0006/html.